Abstract
New sildenafil analogues with an N-acylamido group at the 5′-position of the phenyl ring, 6a-e, were prepared from the readily available starting compound 2 in four straightforward steps. Enzyme assays demonstrated that all the target compounds 6a-e showed higher PDE5 inhibitory activities than sildenafil. It was observed that the PDE5 inhibitory activity was enhanced as the chain length of R group increased, but introduction of the branched alkyl groups such as isopropyl (6d) and cyclohexyl (6e) resulted in the drop of potency compared with 6c. In particular the N-butyrylamido derivative 6c exhibited the highest PDE5 inhibitory activity, and was about 6-fold more potent than sildenafil. However, all the compounds exhibited somewhat weak selectivity (1-3-fold) over PDE6, indicating that the compounds 6a-e have intrinsically lower selectivity than sildenafil.
Original language | English |
---|---|
Pages (from-to) | 1895-1899 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 9 |
Issue number | 7 |
DOIs | |
State | Published - 2001 |